Last reviewed · How we verify

Fluzone vaccine with JVRS-100 adjuvant

Colby Pharmaceutical Company · Phase 1 active Biologic

Fluzone vaccine with JVRS-100 adjuvant is a Biologic drug developed by Colby Pharmaceutical Company. It is currently in Phase 1 development. Also known as: Fluzone vaccine, adjuvant.

At a glance

Generic nameFluzone vaccine with JVRS-100 adjuvant
Also known asFluzone vaccine, adjuvant
SponsorColby Pharmaceutical Company
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Fluzone vaccine with JVRS-100 adjuvant

What is Fluzone vaccine with JVRS-100 adjuvant?

Fluzone vaccine with JVRS-100 adjuvant is a Biologic drug developed by Colby Pharmaceutical Company.

Who makes Fluzone vaccine with JVRS-100 adjuvant?

Fluzone vaccine with JVRS-100 adjuvant is developed by Colby Pharmaceutical Company (see full Colby Pharmaceutical Company pipeline at /company/colby-pharmaceutical-company).

Is Fluzone vaccine with JVRS-100 adjuvant also known as anything else?

Fluzone vaccine with JVRS-100 adjuvant is also known as Fluzone vaccine, adjuvant.

What development phase is Fluzone vaccine with JVRS-100 adjuvant in?

Fluzone vaccine with JVRS-100 adjuvant is in Phase 1.

Related